Syria vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Syria
100.0%
in 2021
Togo
100.0%
in 2024
Syria rank
1st
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Syria
- Togo
How they compare
Syria currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
Across all 10 years both countries report, Syria has been ahead every year.
Syria ranks 1st and Togo ranks 1st of 144 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Syria | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 90.8% | 9.2% | Syria |
| 2020s | 100.0% | 99.0% | 1.0% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Syria or Togo?
- Syria, at 100.0% against 100.0% in Togo as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Syria and Togo?
- 0.0%, with Syria ahead.
- How many years of comparable data are there for Syria and Togo?
- 10 years are reported by both, from 2011 to 2021.
- How do Syria and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Syria ranks 1st and Togo ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.